Corporate Pipeline Strategy • Defined and cross-functionally aligned product pipeline strategy with corporate strategy objectives• Led cross-functional executive teams in pipeline determinations and 5-year operating planning - R&D product pipeline, product life cycle, clinical study outline, and associated 5-year budget planning• Optimized regulatory, clinical study, and reimbursement pathways to maximize ROI of novel glaucoma and ocular surface therapeutic portfolioMarket Access / Reimbursement• Led coding strategy for new technology pipeline - New Technology APC C-code and CPT code pathways • Led highly successful cross functional corporate response to multi-jurisdictional (5 MACs) Medicare Local Coverage Determinations (LCDs) that proposed non-coverage of company's primary technology• Led comprehensive stakeholder education effort in helping reverse and withdraw finalized LCDs (i.e. MIGS LCDs of 2023) - coordinated state and national society - congressional - physician - legal - real world clinical data analytics - patient responsesReporting to CEO

• Created and executed sales, marketing, and reimbursement strategies for portfolio companies - Aquedeon Medical’s cardiothoracic Duett Vascular Graft for aorta reconstruction, Prodeon Medical’s urology implant for the treatment of BPH. • Generated initial revenue as part of strategic commercial validation of minimally invasive surgical technologies.• Led reimbursement strategy including - New Technology Add-On Payment (NTAP), New Technology APC (C-code), and CPT Category 1 & 3 codes. • Recruited, created, and trained our hybrid sales channel: network of independent sales representatives and negotiated corporate channel alliances.• Recruited and managed Key Opinion Leaders (KOL) and developed vital medical society relationships. • Defined branding, digital and lead generation strategies for commercial businesses.Reporting to CEO

• Defined and executed sales and portfolio strategy that drove turn around of approximately $20m ophthalmology-revenue company with $10m debt, into a global ~$50m revenue with $20m+ cash in the bank.• Created new market in ophthalmology for a glaucoma therapeutic, now 30+% of company revenue• Grew global Key Opinion Leaders (KOL) and drove business growth in Asia through infield business development (Greater China, Japan, Korea, India) • Led all aspects of global sales and marketing for new treatments of chronic conditions such as glaucoma and diabetes.• Negotiated multi-year supply agreements with large networks: hospitals, ambulatory surgery centers, ACO (Kaiser HMO), government, and private clinics.• Developed and deployed data driven direct-to-patient digital marketing strategies• Global brand development of MicroPulse laser therapies - retina and glaucomaIncreasing Responsibility• Oct 2016 promoted to VP Global Marketing & Business Development• Aug 2015 promoted to VP Global Sales & Marketing• Nov 2013 promoted to VP Marketing & North American Sales• July 2013 promoted to VP Marketing & Interim US Sales• Mar 2012 promoted to VP Marketing • Sep 2011 joined as VP Marketing MIGS & Laser Systems

ACQUIRED BY IRIDEX• Led Series A fundraising effort - resulted in early exit with a public strategic (Iridex)• Invented and developed novel wound closure disposable technology for surgery - iClip Closure Device - applications include Micro Incisional Glaucoma Surgery (MIGS), cataract, cornea, and pediatric ophthalmology.

ACQUIRED BY ALCON - Disruptive implant technology, Early exit• Leveraged marketing and reimbursement expertise to help close $51m Series B.• Developed payment strategy and created new CPT code. Drove product roadmap and clinical training of implant technology - CyPass® Micro-Stent for glaucoma. • Drove product roadmap of suprachoroidal stent for increased uveoscleral outflow through the collaboration with global glaucoma KOLs.• Developed and executed strategy for Direct to Consumer marketing campaigns for COMPASS Clinical Study - increased investigators’ monthly patient recruitment 50+%.

• One of first North American employees selected for executive fast-track leadership training - graduated in 2009.• Led marketing strategy for surgical microscopy and laser surgery portfolios-responsible for managing P&L for $47 million business. Sales expertise within hospitals and ambulatory surgery centers.• Launched and commercialized the OPMI Lumera® Surgical Microscope. • Accelerated sales revenue of our existing microscope systems in a mature market by 37% year-over-year.• Managed relationship with global cataract and refractive KOLs to achieve market introduction objectives. • Developed North American advertising, digital marketing, public relations, and customer contact strategies.

• Drove product roadmap for retinal surgery devices for ophthalmology - laser probes, illuminated products, and delivery devices. • Developed and launched 8 new product families of Class IIa ophthalmology and ENT surgical instruments - including EasyFit™ SLA, Symphony™ SLA, Stepped™ EndoProbe ®, and OtoProbe™.• Launched disposable products that shifted global business to 50% recurring revenue. • Implemented a private-label business agreement that transitioned into an acquisition.

ACQUIRED BY MICROLINE PENTEX• Followed some of the founders of General Surgical Innovations to their next startup• Designed and developed a consumable instrument to seal/divide arteries in general and cardiovascular surgery, Thermal Ligating Shears (TLS3) ™• Collaborated with thought leading surgeons on identifying surgical protocols within general surgery

ACQUIRED BY TYCO HEALTHCARE• Designed and developed a minimally invasive, laparoscopic fixation device for general surgeons - Talon™ Mesh Fixation Device for hernia repair. Disposable plastic surgical instrument with permanent staple implant.• Performed design and process verification & validation activities

• Designed and developed the propulsion mechanisms for a NASA satellite (Gravity Probe B). • Successfully launched on April 20, 2004. Designed to measure Einstein’s general theory of relativity.• Directed dynamic, thermal, and vibration shock testing of key mechanism for in-orbit positioning thrusters.

• College summer intern (2 years) at Combustion Research Facility• Long term aging study for explosive materialsResponsibilities: Test fixture design and data analysis for ultra-high vacuum mass spectrometer